Cognitive-Behavioral Therapy Enriched With Emotion Regulation Training for Multiple Somatoform Symptoms

NCT01908855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 255

Last updated 2017-08-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether cognitive-behavioral therapy enriched with strategies from emotion regulation training leads to better improvement in somatic symptoms and comorbid problems than cognitive-behavioral therapy alone.

Conditions

  • Somatic Symptom Disorder (DSM-V)

Interventions

BEHAVIORAL

Cognitive-behavioral therapy + emotion regulation training for patients with multiple somatoform symptoms

Cognitive-behavioral therapy + emotion regulation training for patients with multiple somatoform symptoms: 20 weekly sessions individual therapy (à 50) minutes

BEHAVIORAL

Cognitive-behavioral therapy for patients with multiple somatoform symptoms

Cognitive-behavioral therapy for patients with multiple somatoform symptoms: 20 weekly sessions individual therapy (à 50) minutes

Sponsors & Collaborators

  • University of Technology Munich

    collaborator UNKNOWN
  • Central Institute of Mental Health, Mannheim

    collaborator OTHER
  • University of Giessen

    collaborator OTHER
  • University of Wuppertal

    collaborator OTHER
  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • University of Kaiserslautern-Landau

    collaborator OTHER
  • German Research Foundation

    collaborator OTHER
  • Philipps University Marburg Coordination Centre for Clinical Trials

    collaborator UNKNOWN
  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Winfried Rief, Ph.D. · Philipps University Marburg

  • Mathias Berking, Ph.D. · Philipps University Marburg

  • Maria Kleinstäuber, Ph.D. · Philipps University Marburg

  • Japhia-Maria Gottschalk, M.Sc. · Philipps University Marburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-10-31
Completion
2017-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01908855 on ClinicalTrials.gov